[go: up one dir, main page]

IL161235A0 - Fsh composition, its preparation and use - Google Patents

Fsh composition, its preparation and use

Info

Publication number
IL161235A0
IL161235A0 IL16123502A IL16123502A IL161235A0 IL 161235 A0 IL161235 A0 IL 161235A0 IL 16123502 A IL16123502 A IL 16123502A IL 16123502 A IL16123502 A IL 16123502A IL 161235 A0 IL161235 A0 IL 161235A0
Authority
IL
Israel
Prior art keywords
preparation
fsh composition
fsh
composition
Prior art date
Application number
IL16123502A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23323355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL161235(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL161235A0 publication Critical patent/IL161235A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL16123502A 2001-10-22 2002-10-15 Fsh composition, its preparation and use IL161235A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33808801P 2001-10-22 2001-10-22
PCT/EP2002/011501 WO2003035686A2 (en) 2001-10-22 2002-10-15 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments

Publications (1)

Publication Number Publication Date
IL161235A0 true IL161235A0 (en) 2004-09-27

Family

ID=23323355

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16123502A IL161235A0 (en) 2001-10-22 2002-10-15 Fsh composition, its preparation and use
IL161235A IL161235A (en) 2001-10-22 2004-04-01 FSH preparation, its preparation and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161235A IL161235A (en) 2001-10-22 2004-04-01 FSH preparation, its preparation and use

Country Status (24)

Country Link
US (1) US20050085412A1 (uk)
EP (2) EP1621549A3 (uk)
JP (1) JP2005515974A (uk)
KR (1) KR100929971B1 (uk)
CN (1) CN1608078B (uk)
AR (1) AR036926A1 (uk)
AT (1) ATE329930T1 (uk)
AU (1) AU2002340562B2 (uk)
CA (1) CA2464368A1 (uk)
DE (1) DE60212425T2 (uk)
DK (1) DK1438336T3 (uk)
EA (1) EA007030B1 (uk)
ES (1) ES2261740T3 (uk)
HR (1) HRP20040278B1 (uk)
IL (2) IL161235A0 (uk)
ME (1) MEP38608A (uk)
MX (1) MXPA04003352A (uk)
NO (1) NO327966B1 (uk)
PL (1) PL369606A1 (uk)
PT (1) PT1438336E (uk)
RS (1) RS32804A (uk)
UA (1) UA87433C2 (uk)
WO (1) WO2003035686A2 (uk)
ZA (1) ZA200402279B (uk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
AU2007294122B2 (en) * 2006-09-10 2013-03-07 Glycotope Gmbh Use of human cells of myeloid leukaemia origin for expression of antibodies
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
US8742079B2 (en) 2007-08-20 2014-06-03 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
TWI488640B (zh) * 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
JP2012524628A (ja) * 2009-04-22 2012-10-18 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 精巣の機能及び疾患の診断のためのｉｎｖｉｖｏでの１Ｈ磁気共鳴分光法
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
CN102464713A (zh) * 2010-12-21 2012-05-23 上海丽珠制药有限公司 一种卵泡刺激素的制备方法
WO2012098537A1 (en) 2011-01-20 2012-07-26 Protalix Ltd. Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2012131306A1 (en) 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
AR090095A1 (es) * 2011-06-06 2014-10-22 Ferring Bv Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
WO2015158875A1 (en) 2014-04-18 2015-10-22 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
HRP20230787T1 (hr) 2018-05-18 2023-10-27 Glycotope Gmbh Anti-muc1 antitijelo

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
AU736993B2 (en) * 1997-01-16 2001-08-09 Novo Nordisk A/S Practical in vitro sialylation of recombinant glycoproteins
DE69931975T2 (de) * 1998-08-07 2006-10-05 Applied Research Systems Ars Holding N.V. FSH Mimetika zur Behandlung von Infertilität
CA2348430A1 (en) * 1998-10-28 2000-05-04 Baylor College Of Medicine Ovary-specific genes and proteins
DE60032349T2 (de) * 1999-04-26 2007-07-12 Genentech, Inc., South San Francisco Zellenzuchtverfahren für glycoproteine
JP2001299362A (ja) * 1999-12-17 2001-10-30 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ
AU2001231531A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Follicle stimulating hormones

Also Published As

Publication number Publication date
CA2464368A1 (en) 2003-05-01
PL369606A1 (en) 2005-05-02
NO20042061L (no) 2004-07-13
HRP20040278B1 (hr) 2008-03-31
KR20040045885A (ko) 2004-06-02
DE60212425T2 (de) 2006-11-09
EA200400574A1 (ru) 2004-08-26
PT1438336E (pt) 2006-08-31
ATE329930T1 (de) 2006-07-15
EA007030B1 (ru) 2006-06-30
MXPA04003352A (es) 2004-07-08
JP2005515974A (ja) 2005-06-02
AR036926A1 (es) 2004-10-13
ZA200402279B (en) 2005-10-26
WO2003035686A2 (en) 2003-05-01
NO327966B1 (no) 2009-11-02
EP1621549A2 (en) 2006-02-01
CN1608078A (zh) 2005-04-20
EP1621549A3 (en) 2006-03-01
DK1438336T3 (da) 2006-10-02
IL161235A (en) 2009-07-20
HRP20040278A2 (en) 2005-04-30
AU2002340562B2 (en) 2008-10-23
RS32804A (sr) 2007-02-05
KR100929971B1 (ko) 2009-12-04
MEP38608A (en) 2011-02-10
DE60212425D1 (de) 2006-07-27
CN1608078B (zh) 2012-07-25
EP1438336A2 (en) 2004-07-21
ES2261740T3 (es) 2006-11-16
EP1438336B1 (en) 2006-06-14
UA87433C2 (uk) 2009-07-27
WO2003035686A3 (en) 2003-10-09
US20050085412A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
TWI371450B (en) Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
ZA200103580B (en) Aluminosilicate compositions, preparation and use.
IL159015A0 (en) Polypeptides, their preparation and use
EP1463412A4 (en) COMPOSITION COMPRISING WENGUANGUO EXTRACTS, PREPARATION METHODS AND USES THEREOF
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
IL162137A0 (en) D-ribofuranosylthiazolo -3-Ä4,5-dÜpyridimine nucl eosides and uses thereof
MXPA03008961A (es) Composicion de vacuna.
IL154325A0 (en) Anti-il-12 antibodies, compositions, methods and uses
HUP0500983A3 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
HUP0303291A3 (en) Herbicidal composition, preparation and use thereof
AU2001286701A8 (en) Hyaluronan-based antiadhesion compositions, their preparation and use
IL161235A0 (en) Fsh composition, its preparation and use
MXPA03007693A (es) Composicion para la piel.
ZA996814B (en) Aluminosilicate compositions, preparation and use.
HUP0303369A3 (en) Herbicidal composition, preparation and use thereof
IL158397A0 (en) Polypeptides, their preparation and their use
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
MXPA03007314A (es) Composicion para la piel para reducir aceites y grasa de la piel.
GB0026467D0 (en) Compound, composition and use
EG23378A (en) Composition.
HUP0401157A3 (en) Methyl-thieno-benzodiazepine lyophilized formulation, its preparation and use
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HUP0204554A3 (en) Endoparasiticidal composition, preparation and use thereof
AU2002315737A8 (en) Sulphonated dehydrogenated sylvate, the preparation and use
HUP0303682A3 (en) Herbicide composition, preparation and use thereof